ApellisPharma
Apellis Clinical Trial Information
For Additional Information about APL-2 visit http://www.apellis.com
APL-2 Study to Assess the Safety, Tolerability, efficacy and PK of APL-2 in patients with wAIHA or CAD. Phase 2 Trial ClinicalTrials.gov Identifier: NCT03226678 (Plaudit Study) Active, Not Recruiting Last Updated Post February 7, 2020 Estimated Study Completion Date December 2020
